Category : Search result: NHS obesity treatment


Weight loss jab may cure food addiction, study finds

Groundbreaking research reveals Mounjaro injections could revolutionise obesity treatment by targeting food addiction mechanisms in the brain, offering new hope for millions struggling with compulsive eating.

Drug combo reverses liver disease in breakthrough

British scientists make stunning discovery that could transform treatment for millions suffering from liver conditions. Revolutionary research shows existing medications can reverse damage previously thought irreversible.

Wegovy and Mounjaro Weight Loss Jabs Available in UK

Groundbreaking weight loss injections Wegovy and Mounjaro are transforming obesity treatment in the UK, offering new hope for thousands struggling with weight management through both NHS and private healthcare providers.

Weight Loss Jabs Show Revolutionary Results in UK Study

Groundbreaking research shows obesity injections like Mounjaro and Wegovy deliver unprecedented weight loss results, potentially transforming NHS treatment approaches and offering new hope for millions struggling with weight management.

1 in 20 Brits use weight loss jabs as demand soars

Groundbreaking research reveals nearly 5% of UK adults are turning to revolutionary weight loss injections like Wegovy and Mounjaro, with overwhelming majority paying privately amid NHS supply constraints.

Weight loss jabs slash early death risk by 20%

Groundbreaking research shows weight loss injections like Wegovy and Ozempic do more than help shed pounds - they're linked to significant reductions in premature death from cancer, heart disease and diabetes.

NHS staff vote to strike over institutional racism

Thousands of NHS workers across England have overwhelmingly voted for strike action, citing deep-rooted institutional racism and significant pay disparities affecting ethnic minority staff.

Weight Loss Jabs: The Reality When Treatment Stops

New medical research reveals the sobering reality for patients discontinuing popular weight loss injections like Ozempic and Wegovy, with most regaining significant weight within months.

Single women face longer NHS IVF waits

Exclusive analysis reveals stark regional disparities in NHS fertility treatment, with single women experiencing significantly longer waiting times across England despite government promises to end the IVF postcode lottery.

Weight-loss jabs for murderers and rapists at Broadmoor

Broadmoor Hospital prescribes controversial weight-loss injections including Ozempic to dangerous criminals battling obesity, sparking ethical debate about taxpayer-funded treatments for serious offenders.

Ozempic October: Weight-Loss Drug Revolution in UK

Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.

Mounjaro Beats Wegovy in Weight Loss Study

Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.

NHS to prescribe Mounjaro for weight loss in major shift

The NHS is poised to prescribe diabetes medication Mounjaro for weight loss in a groundbreaking move that could help millions of Britons struggling with obesity. Health Secretary Wes Streeting announces major expansion of weight management services.

Weight Loss Jabs: NHS Faces £20 Billion Crisis

Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.

NHS denies 'miracle' weight-loss drug to desperate mother

Exclusive: Carly Stokes, a mother battling severe obesity, is denied access to the 'game-changer' drug Tirzepatide (Mounjaro) on the NHS despite its proven success, sparking outrage and a debate on healthcare funding.

New Weight Loss Jab Helps Shed Over 20% Body Weight

A landmark UK study reveals the new weight loss injection Tirzepatide is significantly more effective than existing treatments, helping patients lose over 20% of their body weight and offering new hope in the fight against obesity.

New Weight Loss Pill Cuts Body Weight By 20%

Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.

Page 1 of 4